NCT04671043View on ClinicalTrials.gov

Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 4, 2022

Primary Completion Date

February 2, 2023

Study Completion Date

February 2, 2023

Conditions
Caffeine and CarbohydrateCarbohydrate OnlyPlacebo
Interventions
DIETARY_SUPPLEMENT

Caffeine and glucose

Caffeine and glucose powder dissolved in water

DIETARY_SUPPLEMENT

Glucose alone

Glucose powder dissolved in water

DIETARY_SUPPLEMENT

Placebo

Artificial sweetener dissolved in water

Trial Locations (1)

3010

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER